Blonder Tongue Laboratories EBIT

The latest EBIT for BDR is $-480K as of March 2025. That compares with $-980K in the prior-year period — up 51.1% year over year. That is below the Technology sector average of $110T. Investors often review this figure alongside Blonder Tongue Laboratories's historical trend and sector peers before judging valuation or financial health.

Over the past year, BDR's EBIT moved from $-980K to $-480K — a 51.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Blonder Tongue Laboratories's operating scale or balance-sheet position.

Against Technology companies, BDR currently prints $-480K for EBIT, while the sector average sits near $110T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Blonder Tongue Laboratories's growth, margins, and balance sheet.

A EBIT figure of $-480K for BDR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Technology average is about $110T. Explore the charts below for those layers of context.

After noting BDR's EBIT ($-480K), review year-over-year change from $-980K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.